ctrl K

Price Alert

Vor Biopharma Inc. (VOR)

NASDAQ: VOR · Real-Time Price · USD

2.13

0.15 (7.58%)

At close: Aug 15, 2025, 3:59 PM

2.12

-0.24%

After-hours: Aug 15, 2025, 05:51 PM EDT

Vor Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	81.95M	31.36M	57.71M	119.8M
Short-Term Investments	9.98M	105.81M	172.54M	87.67M
Long-Term Investments	n/a	2.41M	2.41M	2.41M
Other Long-Term Assets	4.8M	4.81M	2.92M	3.25M
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	380K	475K	2.34M	2.09M
Total Current Assets	96.51M	140.8M	236.95M	214.4M
Property-Plant & Equipment	41.59M	50.1M	57.08M	22.52M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	46.38M	57.32M	62.42M	28.19M
Total Assets	142.89M	198.13M	299.37M	242.59M
Account Payables	1.5M	815K	1.77M	1.54M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	1.84M
Other Current Liabilities	n/a	6.29M	4.95M	752K
Total Current Liabilities	18.61M	15.57M	13.12M	10.15M
Long-Term Debt	n/a	31.83M	n/a	16.17M
Other Long-Term Liabilities	n/a	-31.83M	n/a	-16.17M
Total Long-Term Liabilities	27.61M	31.83M	35.64M	16.17M
Total Liabilities	46.23M	47.4M	48.76M	26.33M
Total Debt	31.83M	35.66M	38.91M	18.01M
Common Stock	13K	7K	7K	4K
Retained Earnings	-456.99M	-340.08M	-222.22M	-130.12M
Comprehensive Income	22K	-77K	-770K	-242.59M
Shareholders Equity	96.66M	150.72M	250.61M	216.26M
Total Investments	9.98M	105.81M	172.54M	87.67M